/VRNOF
VRNOF Stock - Verano Holdings Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$1.74+8.85%
+$0.14 (+8.85%) • Dec 17
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.53
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.91
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VRNOF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.72 – $1.76
TARGET (TP)$2.00
STOP LOSS$1.60
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.67
52W High$1.85
52W Low$0.41
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.26B | $1.24B | $1.18B | $737.85M | $228.53M |
| Gross Profit | $638.41M | $629.88M | $568.44M | $331.02M | N/A |
| Gross Margin | 50.5% | 50.6% | 48.1% | 44.9% | 0.0% |
| Operating Income | $-341,080,433 | $112.38M | $-216,502,517 | $64.71M | N/A |
| Net Income | $-491,624,009 | $-155,543,935 | $-361,660,285 | $-57,507,000 | $38.40M |
| Net Margin | -38.9% | -12.5% | -30.6% | -7.8% | 16.8% |
| EPS | $-1.37 | $-0.45 | $-1.09 | $-0.20 | $0.13 |
Company Overview
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VRNOFBeat Rate
29%
Last 17 quarters
Avg Surprise
+223.3%
EPS vs Estimate
Beats / Misses
5/9
3 met exactly
Latest EPS
$-0.12
Q4 2025
EPS Surprise History
Q1 24
-133.3%
$-0.07vs$-0.03
Q2 24
+87.5%
$-0.01vs$-0.08
Q3 24
0.0%
$-0.05vs$-0.05
Q4 24
-233.3%
$-0.12vs$-0.04
Q1 25
0.0%
$-0.04vs$-0.04
Q2 25
+40.0%
$-0.03vs$-0.05
Q3 25
0.0%
$-0.05vs$-0.05
Q4 25
-140.0%
$-0.12vs$-0.05
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $-0.05 | — | — | — |
Q4 2025 | Oct 29, 2025 | $-0.05 | $-0.12 | -140.0% | ✗ MISS |
Q3 2025 | Aug 7, 2025 | $-0.05 | $-0.05 | 0.0% | = MET |
Q2 2025 | May 8, 2025 | $-0.05 | $-0.03 | +40.0% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $-0.04 | $-0.04 | 0.0% | = MET |
Q4 2024 | Nov 7, 2024 | $-0.04 | $-0.12 | -233.3% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $-0.05 | $-0.05 | 0.0% | = MET |
Q2 2024 | May 8, 2024 | $-0.08 | $-0.01 | +87.5% | ✓ BEAT |
Q1 2024 | Mar 15, 2024 | $-0.03 | $-0.07 | -133.3% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $-0.02 | $-0.03 | -73.4% | ✗ MISS |
Q3 2023 | Aug 8, 2023 | $-0.03 | $-0.04 | -26.7% | ✗ MISS |
Q2 2023 | May 10, 2023 | $-0.07 | $-0.03 | +57.1% | ✓ BEAT |
Q1 2023 | Mar 30, 2023 | $-0.00 | $0.04 | +5733.8% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | $-0.01 | $-0.13 | -1200.0% | ✗ MISS |
Q3 2022 | Aug 16, 2022 | $-0.01 | $-0.03 | -203.3% | ✗ MISS |
Q2 2022 | May 25, 2022 | $0.07 | $-0.02 | -128.6% | ✗ MISS |
Q1 2022 | Feb 14, 2022 | — | $-0.48 | — | — |
Q4 2021 | Nov 16, 2021 | $0.16 | $0.33 | +106.3% | ✓ BEAT |
Q3 2021 | Aug 10, 2021 | $0.19 | $0.02 | -89.5% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about VRNOF
What is VRNOF's current stock price?
Verano Holdings Corp. (VRNOF) is currently trading at $1.74 per share. The stock has moved +8.85% today.
What is the analyst price target for VRNOF?
No analyst price targets are currently available for this stock.
What sector is Verano Holdings Corp. in?
Verano Holdings Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is VRNOF's market cap?
Verano Holdings Corp. has a market capitalization of $0.63 billion, making it a small-cap company.
Does VRNOF pay dividends?
No, Verano Holdings Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAGYTF
Allergy Therapeutics plc
$0.11
Mkt Cap: $0.5B
BHHKF
Craftport Cannabis Corp.
$0.00
Mkt Cap: $0.0B
CLHLF
COLTENE Holding AG
$61.16
Mkt Cap: $0.4B
CRLBF
Cresco Labs Inc.
$1.30
Mkt Cap: $0.4B
GLASF
Glass House Brands Inc.
$9.41
Mkt Cap: $0.7B
HUMDF
Hua Medicine (Shanghai) Ltd.
$0.41
Mkt Cap: $0.4B
KHTRF
Knight Therapeutics Inc.
$4.41
Mkt Cap: $0.4B
LBLTF
Lattice Biologics Ltd.
$0.00
Mkt Cap: $0.0B
MDCLF
MedinCell S.A.
$6.98
Mkt Cap: $0.2B
MNFSF
ManifestSeven Holdings Corporation
$0.00
Mkt Cap: $0.0B
Explore stocks similar to VRNOF for comparison